Clinical islet transplantation at the University of California, San Francisco.

Clinical transplants

Volumn , Issue , 2010, Pages 235-243

  Posselt, Andrew M ^a   Szot, Gregory L ^b   Frassetto, Lynda A ^b   Masharani, Umesh ^b   Stock, Peter G ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; IMMUNOSUPPRESSIVE AGENT; INSULIN;

ARTICLE; GRAFT REJECTION; GRAFT SURVIVAL; HEALTH CARE QUALITY; HUMAN; IMMUNOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET TRANSPLANTATION; PROGRAM DEVELOPMENT; TIME; TRANSPLANTATION; TREATMENT OUTCOME; UNITED STATES; UNIVERSITY HOSPITAL;

ACADEMIC MEDICAL CENTERS; DIABETES MELLITUS, TYPE 1; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; HYPOGLYCEMIC AGENTS; IMMUNOSUPPRESSIVE AGENTS; INSULIN; ISLETS OF LANGERHANS TRANSPLANTATION; PROGRAM DEVELOPMENT; PROGRAM EVALUATION; SAN FRANCISCO; TIME FACTORS; TISSUE AND ORGAN PROCUREMENT; TREATMENT OUTCOME;

EID: 79960073305     PISSN: 08909016     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)